DeutschNewstral
Article
bizjournals.com on 2020-09-29 18:49
Bucks County biotech gets FDA approval to begin mid-stage testing of experimental Covid-19 therapy
Related news
- FDA rejects AstraZeneca's experimental diabetes therapybizjournals.com
FDA grants emergency approval to experimental COVID-19 antibody therapynewatlas.com- WRaleigh biotech startup receives FDA approval for testosterone therapywraltechwire.com
- FDA grants two key designations to Passage Bio's experimental Krabbe disease therapybizjournals.com
- FDA rejects NRx's breakthrough designation bid for experimental Covid-19 therapy; stock price fallsbizjournals.com
- FDA approves expanded access to Wilmington company's experimental Covid-19 therapybizjournals.com
- Biotech delays U.S. gene therapy launch due to outbreak, FDA discordbizjournals.com
Dallas-based biotech firm Taysha drops gene therapy following FDA meetingDallas News- Chapel Hill biotech gets FDA green light to test heart disease therapybizjournals.com
- After returning PPP, Bucks County biotech working on Covid-19 therapy expects to raise $20Mbizjournals.com
- FSD Pharma gets FDA approval to begin mid-stage testing of potential Covid-19 therapybizjournals.com
FDA Backs Experimental 'Female Viagra'huffingtonpost.com
FDA Issues Gene Therapy Guidancesjdsupra.com
FDA approves gene therapy drugKING 5
FDA OKs experimental blood test for ZikaThe Salt Lake Tribune
FDA skeptical of experimental ALS drugjournalrecord.com- Bucks County medical device company gets FDA marketing clearance for flagship productbizjournals.com
- Bucks County company gets FDA approval for low-cost weight loss drugbizjournals.com
- Bucks County generic drug company charged with conspiracy to defraud the FDAbizjournals.com
FDA Approves First Generic Biotech Druglive.wsj.com